Cardiac Hypertrophy Changes Compartmentation of cAMP in Non-Raft Membrane Microdomains

Area of Science:

• Cardiology
• Molecular Biology
• Cellular Physiology

Background:

• Cyclic adenosine monophosphate (cAMP) is a crucial second messenger in cardiac function and disease.
• Distinct cAMP signaling microdomains exist in adult mouse ventricular myocytes (AMVMs) plasma membrane, associated with raft and non-raft sarcolemma.
• The impact of cardiac disease on cAMP signaling in non-raft membrane microdomains remains poorly understood.

Purpose of the Study:

• To investigate how cardiac hypertrophy affects cAMP signaling specifically within non-raft membrane microdomains of AMVMs.
• To characterize the differential regulation of cAMP signaling in distinct membrane microdomains during cardiac remodeling.

Main Methods:

• Generation of a novel transgenic mouse line expressing a FRET-based cAMP biosensor (E1-CAAX) targeted to non-lipid raft membrane microdomains.
• Induction of cardiac hypertrophy via pressure overload in the transgenic mouse model.
• Detection and analysis of cAMP dynamics in specific microdomains using the FRET biosensor.

Main Results:

• Specific changes in phosphodiesterase 3 (PDE3)-dependent compartmentation of beta-adrenergic receptor-induced cAMP were detected in non-raft membrane microdomains.
• These cAMP signaling changes in non-raft microdomains differed significantly from those observed in caveolin-rich sarcolemma.
• The findings indicate differential regulation and distinct responses of raft and non-raft membrane microdomains to cardiac remodeling.

Conclusions:

• Cardiac hypertrophy induced by pressure overload leads to specific alterations in cAMP signaling within non-raft membrane microdomains of AMVMs.
• These changes are distinct from those occurring in caveolin-rich domains, highlighting microdomain-specific regulation.
• The study provides novel insights into the compartmentalized nature of cAMP signaling in the diseased heart.